PDK1 inhibitor 7

CAS No. 1001409-50-2

PDK1 inhibitor 7( PDK1 inhibitor MP7 )

Catalog No. M10016 CAS No. 1001409-50-2

A potent, selective PDK1 inhibitor with IC50 of 1 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 237 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PDK1 inhibitor 7
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective PDK1 inhibitor with IC50 of 1 nM.
  • Description
    A potent, selective PDK1 inhibitor with IC50 of 1 nM, displays >3,000-fold selectivity against a panel of 256 kinases; specifically inhibits cellular PDK1 T-loop phosphorylation (Ser-241), inhibits p-RSK S221 in PC-3 cells with EC50 of 300 nM, inhibits colony formation in a subset of cancer cell lines (4 of 10) and primary xenograft tumor lines (9 of 57).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PDK1 inhibitor MP7
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PDK
  • Recptor
    PDK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1001409-50-2
  • Formula Weight
    516.505
  • Molecular Formula
    C28H22F2N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL 193.61 mM;H2O : < 0.1 mg/mL
  • SMILES
    C1=CC=C(C=C1)C(COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F
  • Chemical Name
    (R)-1-(3,4-difluorobenzyl)-2-oxo-N-(2-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)oxy)-1-phenylethyl)-1,2-dihydropyridine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nagashima K, et al. J Biol Chem. 2011 Feb 25;286(8):6433-48.
molnova catalog
related products
  • KPLH1130

    KPLH1130 improves glucose tolerance in HFD-fed mice.?KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.

  • 6-Bromo-4-methoxypyr...

    6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.

  • GSK2334470

    GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay.